News

5/3/2016
Unilabs delivers robust start to 2016 with on target Q1 performance
Unilabs, one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services, closed Q1 above expectations in a robust start to the new financial year and also confirms it is on track to deliver 2016 targets.
3/22/2016
Unilabs Reports Strong Fourth Quarter – and Record Full Year – 2015 Financial Results
Unilabs, one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services, announced further robust growth today, reporting that for the quarter ending 31st December 2015, revenue was €180.1m, compared to €165.9m in Q4 2014.  The results show a significant and positive organic sales growth of 5.0% (CER) leading to organic EBITDA growth vs Q4 2014 of 24.5% (CER). This marks the company’s 6th successive quarter of positive organic EBITDA growth and 5th with a double digit growth rate.

Our Partnerships, Expertise & Network

We are a partner of choice and leading provider of outsourced diagnostic services with more than 200 diagnostic contracts across Europe.
Our services include: laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services.
With operations in 12 countries, we are positioned as a regional leader with one of the broadest geographic coverage in Europe.